Septerna Inc

Research Septerna Inc (SEPN) on Bullrun: market cap USD 1.57B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSEPN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.57B
• Financial periodFY2025
• RevenueUSD 45.95M
• Revenue growth4174.5%
• Net income-USD 48.88M
• Free cash flowUSD 109.67M

Valuation Snapshot

latest market cap is USD 1.57B.

About Septerna Inc

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases;

Frequently asked questions

What is Septerna Inc's market cap?

Septerna Inc's market capitalization is USD 1.57B.

What does Septerna Inc do?

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.